Barriers to Treatment Regimen Adherence in Indian Women with Polycystic Ovarian Syndrome

Overview

Journal J Family Med Prim Care

Specialty Public Health

Date 2022 Nov 17

PMID 36387674

Authors

Smitha Moonjelly Vijayan

H Kalaivani

Subarna Mitra

Joseph John

A Anila

Damini

Linimol Boban

Pritha Chowdhury

Sriparna Gayen

Affiliations

Soon will be listed here.

Abstract

Background: Polycystic ovarian syndrome (PCOS) is a hormonal disorder that affects women of the reproductive age group. Its treatment regimen comprises medication and lifestyle modifications. However, non-adherence to the treatment regimen is the most commonly faced problem among women due to various barriers, resulting in complications like insulin resistance, hyperlipidemia, obesity, and infertility. Primary care physicians see patients with this disorder either at the initiation of treatment or on follow-up care after specialist consultation. So, understanding the barriers to treatment compliance, from a woman's perspective and finding the solution to the same is crucial to successful therapy.

Objectives: The present study aims to assess adherence to the treatment regimen and its barriers among women with PCOS and its associated factors.

Methods: A cross-sectional study among 224 women who met the inclusion criteria responded through a Google form. Self-reports were obtained by a demographic proforma, medication adherence rating scale, and barriers assessment questionnaire.

Results: Only a third of the women (32.1%) were fully adherent, 36.3% were partially adherent, and 31.6% were non-adherent. The most common barriers among women were lack of knowledge regarding the disease and its management, side effects of the treatment, long duration of the therapy, no relief of symptoms, bland diet, and lack of physical exercise. Treatment adherence was associated with socioeconomic status ( = 0.001) among women with PCOS.

Conclusion: Adherence to the treatment regimen in PCOS was poor. Successful adherence depends on how patients understand the severe implications of non-adherence to the prescribed treatment and adjust to lifestyle modifications related barriers. It is also vital for health care providers and patients to identify these barriers, address them and refine treatment strategies.

Citing Articles

Understanding metabolic patterns in polycystic ovary syndrome: Comparing lean and obese women at a family medicine clinic.

Arunachalam R, Priya K, Brindha R, Parthiban K J Family Med Prim Care. 2024; 13(5):1837-1842.

PMID: 38948599 PMC: 11213445. DOI: 10.4103/jfmpc.jfmpc_1425_23.

Knowledge, Attitude, and Practice of Lifestyle Modifications Among Saudi Women Diagnosed With Polycystic Ovary Syndrome (PCOS).

Aljuaid A, Sindi H, Alhadi W, Abu Zayied I, Althobaiti L, Imran I Cureus. 2023; 15(11):e49398.

PMID: 38146573 PMC: 10749713. DOI: 10.7759/cureus.49398.

References

Ko H, Teede H, Moran L . Analysis of the barriers and enablers to implementing lifestyle management practices for women with PCOS in Singapore. BMC Res Notes. 2016; 9:311. PMC: 4910192. DOI: 10.1186/s13104-016-2107-2. View

Kyrou I, Karteris E, Robbins T, Chatha K, Drenos F, Randeva H . Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic. BMC Med. 2020; 18(1):220. PMC: 7360476. DOI: 10.1186/s12916-020-01697-5. View

Bazarganipour F, Taghavi S, Allan H, Hosseini N . Facilitating and inhibiting factors related to treatment adherence in women with polycystic ovary syndrome: A qualitative study. Int J Reprod Biomed. 2018; 15(9):553-560. PMC: 5894471. View

Barrea L, Arnone A, Annunziata G, Muscogiuri G, Laudisio D, Salzano C . Adherence to the Mediterranean Diet, Dietary Patterns and Body Composition in Women with Polycystic Ovary Syndrome (PCOS). Nutrients. 2019; 11(10). PMC: 6836220. DOI: 10.3390/nu11102278. View

Ganie M, Rashid A, Sahu D, Nisar S, Wani I, Khan J . Prevalence of polycystic ovary syndrome (PCOS) among reproductive age women from Kashmir valley: A cross-sectional study. Int J Gynaecol Obstet. 2020; 149(2):231-236. DOI: 10.1002/ijgo.13125. View

Nidhi R, Padmalatha V, Nagarathna R, Amritanshu R . Prevalence of polycystic ovarian syndrome in Indian adolescents. J Pediatr Adolesc Gynecol. 2011; 24(4):223-7. DOI: 10.1016/j.jpag.2011.03.002. View

Goodman N, Cobin R, Futterweit W, Glueck J, Legro R, Carmina E . AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1. Endocr Pract. 2015; 21(11):1291-300. DOI: 10.4158/EP15748.DSC. View

Deswal R, Nanda S, Ghalaut V, Roy P, Dang A . Cross-sectional study of the prevalence of polycystic ovary syndrome in rural and urban populations. Int J Gynaecol Obstet. 2019; 146(3):370-379. DOI: 10.1002/ijgo.12893. View

Wekker V, van Dammen L, Koning A, Heida K, Painter R, Limpens J . Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis. Hum Reprod Update. 2020; 26(6):942-960. PMC: 7600286. DOI: 10.1093/humupd/dmaa029. View

10.

Parker M, Warren A, Nair S, Barnard M . Adherence to treatment for polycystic ovarian syndrome: A systematic review. PLoS One. 2020; 15(2):e0228586. PMC: 7017995. DOI: 10.1371/journal.pone.0228586. View

11.

Li S, He A, Yang J, Yin T, Xu W . A logistic regression analysis of factors related to the treatment compliance of infertile patients with polycystic ovary syndrome. J Reprod Med. 2011; 56(7-8):325-32. View

12.

Teede H, Misso M, Boyle J, Garad R, McAllister V, Downes L . Translation and implementation of the Australian-led PCOS guideline: clinical summary and translation resources from the International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Med J Aust. 2018; 209(S7):S3-S8. DOI: 10.5694/mja18.00656. View

13.

Hoeger K, Dokras A, Piltonen T . Update on PCOS: Consequences, Challenges, and Guiding Treatment. J Clin Endocrinol Metab. 2020; 106(3):e1071-e1083. DOI: 10.1210/clinem/dgaa839. View

14.

Lim S, Kakoly N, Tan J, Fitzgerald G, Bahri Khomami M, Joham A . Metabolic syndrome in polycystic ovary syndrome: a systematic review, meta-analysis and meta-regression. Obes Rev. 2018; 20(2):339-352. DOI: 10.1111/obr.12762. View

15.

Love J, McKenzie J, Nikokavoura E, Broom J, Rolland C, Johnston K . The experiences of women with polycystic ovary syndrome on a very low-calorie diet. Int J Womens Health. 2016; 8:299-310. PMC: 4959593. DOI: 10.2147/IJWH.S100385. View

16.

Brennan L, Teede H, Skouteris H, Linardon J, Hill B, Moran L . Lifestyle and Behavioral Management of Polycystic Ovary Syndrome. J Womens Health (Larchmt). 2017; 26(8):836-848. DOI: 10.1089/jwh.2016.5792. View

17.

Ganie M, Kalra S . Polycystic ovary syndrome - A metabolic malady, the mother of all lifestyle disorders in women - Can Indian health budget tackle it in future?. Indian J Endocrinol Metab. 2011; 15(4):239-41. PMC: 3193771. DOI: 10.4103/2230-8210.85571. View

18.

Brady C, Mousa S, Mousa S . Polycystic ovary syndrome and its impact on women's quality of life: More than just an endocrine disorder. Drug Healthc Patient Saf. 2011; 1:9-15. PMC: 3108690. DOI: 10.2147/dhps.s4388. View

19.

Daniilidis A, Dinas K . Long term health consequences of polycystic ovarian syndrome: a review analysis. Hippokratia. 2009; 13(2):90-2. PMC: 2683463. View

20.

Pena A, Witchel S, Hoeger K, Oberfield S, Vogiatzi M, Misso M . Adolescent polycystic ovary syndrome according to the international evidence-based guideline. BMC Med. 2020; 18(1):72. PMC: 7092491. DOI: 10.1186/s12916-020-01516-x. View